Pamidronate and Zoledronic Acid: A Comparative Review of Intravenous NitrogenContaining Bisphosphonates
Bisphosphonates have long represented a major therapeutic class in the management of diseases characterised by excessive bone resorption. Since their introduction in the 1970s, they have transformed the treatment of metabolic bone disorders, osteoporosis, malignancy-related hypercalcaemia and skeletal complications of metastatic disease. Among this group, pamidronate and zoledronic acid stand as two of the most […]
Formulation and Stability Strategies for Nimodipine: From Particle Engineering to GMP Production
Nimodipine is a dihydropyridine calciumchannel blocker with pronounced cerebrovascular selectivity, used clinically to protect the brain from ischemic injury by preferentially relaxing cerebral arterial smooth muscle while limiting systemic hypotension. Its primary indication is for the prevention and treatment of neurological deficits following aneurysmal subarachnoid haemorrhage (SAH), where nimodipine reduces the risk of delayed cerebral […]
Protamine Sulfate in the EU: Analytical Validation, FinishedForm Control and Regulatory Pathways
Protamine sulfate is an argininerich polypeptide used as the clinical antidote to heparin and as a functional excipient in selected parenteral and combination products. Its mechanism of action is electrostatic binding to negatively charged heparin, forming stable complexes that rapidly neutralise anticoagulant activity. Clinically, protamine is employed primarily in cardiovascular and surgical settings, including cardiopulmonary […]
From Racemate to Single Enantiomer
Pharmacokinetic Differences, Clinical Context and MediPharm’s Process Expertise Gastric acid has long been recognised as a key factor in the physiology of the upper gastrointestinal tract, playing essential roles in protein digestion, mineral absorption and providing a natural defense against bacterial infections to a certain degree. However, inappropriate levels of gastric acid underlie several widespread […]
Lyophilization for Biologics and Parenteral Formulations: Development, Cycle Design and GMP Implementation
Lyophilization, or freeze‑drying, is a critical stabilization technology for biologics and labile parenteral formulations that converts a solution into a solid state by sequentially freezing, sublimating ice during primary drying and removing bound water during secondary drying. When appropriately designed, a lyophilized product maintains chemical integrity and conformational stability of the active substance, mitigates hydrolytic […]
Nucleoside and Nucleotide Analogues: Chemistry, Manufacturing and CMC Strategies for Regulatory Submission
Scientific background and therapeutic context Nucleosides, comprising a nitrogenous base covalently linked to ribose or deoxyribose, are fundamental precursors for nucleic acid biosynthesis and form the chemical core of oligonucleotide monomers used in solid‑phase synthesis. Chemically manufactured DNA phosphoramidites typically contain a protected 5′‑hydroxyl (5′‑DMT) and a 3′‑phosphoramidite bearing cyanoethyl and diisopropylamine moieties, while RNA […]